Dengue vaccine: a hidden risk to Aedes aegypti control in Brazil
Open Access
- 23 June 2026
- journal article
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 17 (4) , 322-325
Abstract
Osong Public Health and Research PerspectivesKeywords
This publication has 25 references indexed in Scilit:
- Effectiveness of mass dengue vaccination with CYD-TDV (Dengvaxia®) in the state of Paraná, Brazil: integrating case-cohort and case-control designsThe Lancet Regional Health - Americas, 2024
- Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trialThe Lancet, 2023
- An examination and extension of the Peltzman effect during the Covid-19 pandemicCurrent Research in Ecological and Social Psychology, 2023
- COVID-19 Vaccination is not a Sufficient Public Policy to face Crisis Management of next Pandemic ThreatsPublic Organization Review, 2022
- Zika virus—an update on the current efforts for vaccine developmentHuman Vaccines & Immunotherapeutics, 2020
- Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trialThe Lancet Infectious Diseases, 2020
- Effect of Dengue Serostatus on Dengue Vaccine Safety and EfficacyNew England Journal of Medicine, 2018
- Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trialsThe Lancet, 2018
- Will people change their vector-control practices in the presence of an imperfect dengue vaccine?Epidemiology and Infection, 2013
- Detection of Chikungunya virus in Aedes aegypti during 2011 outbreak in Al Hodayda, YemenActa Tropica, 2012